Back to Journals » International Journal of Nanomedicine » Volume 20

Topical Ocular Delivery to Laser-Induced Choroidal Neovascularization by Dual Internalizing RGD and TAT Peptide-Modified Nanoparticles [Corrigendum]

Authors Chu YC, Chen N, Yu HJ, Mu HJ, He B, Hua HC, Wang AP, Sun KX

Received 8 August 2025

Accepted for publication 8 August 2025

Published 11 August 2025 Volume 2025:20 Pages 9883—9884

DOI https://doi.org/10.2147/IJN.S559353



Chu YC, Chen N, Yu HJ, et al. Int J Nanomedicine. 2017;12:1353–1368.

The authors have advised due to an error that occurred inadvertently at the time of figure assembly, Figures 5 and 6 on pages 1362 and 1363, respectively, are inorrect. The correct figures are as follows.

Figure 5 Fluorescence microscopy images of the cellular uptake of NPs with 5, 20, and 40% TAT–PEG –PLGA in HUVECs.

Abbreviations: HUVECs, human umbilical vein endothelial cells; iRGD, internalizing arginine-glycine-aspartic acid; NP, nanoparticle; PEG, poly(ethylene glycol); PLGA, poly(lactic-co-glycolic acid); TAT, transactivated transcription.

Notes: iRGD–5% TAT-Nile red-NP, iRGD and TAT dual-modified NPs labeled with Nile red with 5% TAT–PEG–PLGA; iRGD–20% TAT-Nile red-NP, iRGD and TAT dual-modified NPs labeled with Nile red with 20% TAT–PEG–PLGA; iRGD–40% TAT-Nile red-NP, iRGD and TAT dual-modified NPs labeled with Nile red with 40% TAT–PEG –PLGA.

Figure 6 Cellular uptake images for different NPs after treating HUVECs at 1, 3, and 6 h.

Abbreviations: HUVECs, human umbilical vein endothelial cells; iRGD, internalizing arginine-glycine-aspartic acid; mPEG, methoxy-poly(ethylene glycol); NP, nanoparticle; PLGA, poly(lactic-co-glycolic acid); TAT, transactivated transcription.

Notes: The blue fluorescence and the red fluorescence belong to Hoechst 33342 and NPs labeled with Nile red, respectively. mPEG–PLGA-Nile red-NP, mPEG–PLGA NPs labeled with Nile red; iRGD-Nile red-NP, iRGD-modified NPs labeled with Nile red; TAT-Nile red-NP, TAT-modified NPs labeled with Nile red; iRGD–TAT-Nile red-NP, iRGD and TAT dual-modified NPs labeled with Nile red.

The authors apologize for the errors and advise they do not affect the results and conclusions of the paper.


Read the original article


Creative Commons License © 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms and incorporate the Creative Commons Attribution - Non Commercial (unported, 4.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.